As entry-level tasks are automated, the focus of training will shift to judgment, simulation, and continuous upskilling.

Swedish online poker star Niklas 'Lena900' Astedt beats 35-entry field in €50,000 event at EPT Paris to earn $738,208.

My priority now is longevity and not so much how I look, as I was in my 20s,” she tells Fit&Well. “I want to preserve muscle, ...

The benefits of exercise are well known, but now researchers have determined how many weekly minutes of movement can help protect against a common form of liver disease. Around one in five people in ...

We all start January 1 motivated to get in the gym, but according to research, most of us abandon ambitious goals of exercising, eating healthy and ditching the booze just nine days into the New Year.

This haunting photograph captures the moment sparklers in champagne bottles seemingly ignite a fire at a Swiss ski resort bar, resulting in a tragedy that has claimed dozens of lives. The death toll ...

A significant amount of food will be thrown away before and after Christmas because people are shopping at the wrong time, experts say. Food storage experts say the ideal time to fully stock the ...

Abstract: In recent years, both online retail and video hosting service have been exponentially grown. In this paper, a novel deep neural network, called AsymNet, is proposed to explore a new ...

Abbot Laboratory has announced a deal to acquire Madison-based Exact Sciences for approximately $21 billion. Exact Sciences, known for its Cologuard cancer screening test, was founded in 1995 and ...

Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. Madison-based Exact Sciences, a maker and provider of cancer ...

The acquisition will allow the diagnostics giant to enter the rapidly growing market for cancer tests Exact Sciences sells Cologuard, the at-home test for colorectal cancer that allows some patients ...

Abbott announced Thursday morning that it is acquiring Exact Sciences for $21 billion. The deal values Exact Sciences at $105 per share, representing a 22% premium to the cancer screening company’s ...